Exploring factors related to cervical and endometrial cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study aims to investigate the relationship between cervical and endometrial cancers and various demographic, lifestyle, and pregnancy-related factors, as well as disease history. It will also analyze biological specimens using omics tests to identify potential diagnostic and prognostic biomarkers. Eligible participants will be women aged 20-75 with a confirmed diagnosis of cervical or endometrial cancer attending health check-ups. The study does not involve any interventions, focusing instead on data collection and analysis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 20-75 years;
* Women with cervical cancer or endometrial cancer with a definite pathological diagnosis for the first time;
* Women attending a health check-up;
* Obtain informed consent and sign an informed consent form.

Exclusion Criteria:

* Patients who are unable to cooperate with the investigations such as mental disorders or cognitive impairment；
* Patients with cancer other than cervical cancer or endometrial cancer;
* Women who have received hysterectomy or pelvic radiation therapy previously.

Where it's running

• Women's hospital school of medicine zhejiang university
  Hangzhou, Zhejiang, China Recruiting

Study contacts

• Principal investigator: Hui Wang, PhD — Women's Hospital School Of Medicine Zhejiang University
• Study coordinator: Hui Wang, PhD
• Email: wang71hui@zju.deu.cn
• Phone: 0571-89998857

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy

  This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.

  Recruiting Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong · NCT07895212

• Radiotherapy for gynecologic cancer with up to 10 metastatic sites

  This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.

  Recruiting Affidea Nu-med Center of Oncological DIagnostics and Therapy · Zamość · NCT07883798

• Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy

  The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.

  Recruiting The Second People's Hospital of Huai'an · Huai'an, Jiangsu · NCT07860203

• First-in-human test of HH160 in people with advanced solid tumors

  HH160 is being tested to see if it is safe and how it behaves in the body, to see if it has early signs of helping various advanced cancers in adults.

  Recruiting at 3 sites Phase 1 Huahui Health · Waratah, New South Wales and 2 other locations · NCT07623369

• Online adaptive radiotherapy vs standard radiotherapy after surgery for cervical or endometrial cancer

  A national, multi-center study will test whether online adaptive radiotherapy can reduce side effects and improve quality of life compared with standard radiotherapy in adults after surgery for cervical or endometrial cancer.

  Recruiting Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT07584161

• CAIX-targeted 18F-T2 PET/CT imaging in solid tumors

  This study tests a CAIX-specific radioactive tracer to see if PET/CT can help visualize solid tumors and checks safety and radiation exposure in adults with certain cancers.

  Recruiting Peking University First Hospital · Beijing, Beijing Municipality · NCT07557225

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.